Contemporary Amperex Technology Co Ltd
SZSE:300750
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
211.39
415.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Contemporary Amperex Technology Co Ltd
Total Receivables
Contemporary Amperex Technology Co Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Contemporary Amperex Technology Co Ltd
SZSE:300750
|
Total Receivables
ÂĄ112.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Tbea Co Ltd
SSE:600089
|
Total Receivables
ÂĄ34B
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Gongniu Group Co Ltd
SSE:603195
|
Total Receivables
ÂĄ335m
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Sieyuan Electric Co Ltd
SZSE:002028
|
Total Receivables
ÂĄ9.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
18%
|
CAGR 10-Years
15%
|
|
|
EVE Energy Co Ltd
SZSE:300014
|
Total Receivables
ÂĄ21.6B
|
CAGR 3-Years
29%
|
CAGR 5-Years
43%
|
CAGR 10-Years
46%
|
|
|
Sungrow Power Supply Co Ltd
SZSE:300274
|
Total Receivables
ÂĄ38.3B
|
CAGR 3-Years
38%
|
CAGR 5-Years
29%
|
CAGR 10-Years
29%
|
|
Contemporary Amperex Technology Co Ltd
Glance View
Contemporary Amperex Technology Co., Limited, commonly known as CATL, has emerged as a colossal force in the energy sector, captivating the world with its unparalleled expertise in lithium-ion battery manufacturing. Founded in 2011 in Ningde, China, CATL quickly rose to prominence by riding the crest of the global transition towards sustainability and electric mobility. The company intricately weaves its operations around a core strategic vision: being at the forefront of innovation in battery technology. Its research and development are intensely focused on enhancing battery efficiency, extending lifespan, and reducing costs. With the ability to produce power solutions that range from small consumer electronics to large-scale energy storage systems, CATL has firmly entrenched itself as a key player in powering the future. The strategic alliances with automotive giants such as Tesla, BMW, and Volkswagen underscore its pivotal role in shaping the electric vehicle revolution. Revenue streams for CATL primarily flow from its robust battery production lines, which cater to an ever-expanding electric vehicle (EV) market and renewable energy storage solutions. The company's business model thrives on economies of scale—leveraging its massive production capacity to maintain cost competitiveness while securing long-term supply contracts. CATL has also invested heavily in the upstream supply chain, nurturing partnerships with miners and securing essential raw materials like lithium and cobalt. In parallel, it proactively explores recycling initiatives to reclaim these valuable resources, further solidifying its commitment to environmental stewardship. Through these integrated efforts, CATL not only boosts its profitability but also ensures a sustainable supply of critical materials. This strategic foresight and operational precision cement CATL's standing as a leader in the fast-evolving landscape of green energy, steering towards a future defined by sustainability and innovation.
See Also
What is Contemporary Amperex Technology Co Ltd's Total Receivables?
Total Receivables
112.4B
CNY
Based on the financial report for Sep 30, 2025, Contemporary Amperex Technology Co Ltd's Total Receivables amounts to 112.4B CNY.
What is Contemporary Amperex Technology Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
40%
Over the last year, the Total Receivables growth was 1%. The average annual Total Receivables growth rates for Contemporary Amperex Technology Co Ltd have been 10% over the past three years , 40% over the past five years .